PTAB Refuses Post-Grant Reviews Of 2 Psilocybin Patents

By Adam Lidgett ( June 23, 2022, 5:47 PM EDT) -- The Patent Trial and Appeal Board has said it won't be reviewing a pair of patents on large-scale production of psilocybin for medicinal purposes, saying the patent challenger wasn't likely to succeed in its cases....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

PTAB Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Date Filed

Subscribers Only

Law Firms